PUBLISHER: The Business Research Company | PRODUCT CODE: 1669621
PUBLISHER: The Business Research Company | PRODUCT CODE: 1669621
Fill-finish pharmaceutical contract manufacturing involves outsourcing the final stages of the pharmaceutical manufacturing process to specialized contract manufacturing organizations (CMOs).
The primary product types in fill-finish pharmaceutical contract manufacturing include prefilled syringes, vials, cartridges, and other products. Prefilled syringes are pre-loaded with a specific dose of medication, ensuring precise dosing, sterility, and quality control through the aseptic fill-finish pharmaceutical contract manufacturing processes. This outsourcing approach is employed for both large molecules and small molecules, with biopharmaceutical companies and pharmaceutical companies serving as the key end-users.
The fill-finish pharmaceutical contract manufacturing research report is one of a series of new reports from The Business Research Company that provides fill-finish pharmaceutical contract manufacturing market statistics, including the fill-finish pharmaceutical contract manufacturing industry's global market size, regional shares, competitors with a fill-finish pharmaceutical contract manufacturing market share, detailed fill-finish pharmaceutical contract manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the fill-finish pharmaceutical contract manufacturing industry. This fill-finish pharmaceutical contract manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The fill-finish pharmaceutical contract manufacturing market size has grown strongly in recent years. It will grow from $11.84 billion in 2024 to $12.86 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increasing demand for biologics, outsourcing trends, globalization of pharmaceutical supply chains, quality assurance emphasis, cost containment measures
The fill-finish pharmaceutical contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $18.98 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to emerging market opportunities, pandemic preparedness, digital transformation, sustainability and green initiatives, personalized medicine expansion. Major trends in the forecast period include flexible manufacturing solutions, partnerships and collaborations, regulatory compliance and serialization, focus on sustainability and green practices, automation and robotics integration.
The expected growth in the fill-finish pharmaceutical contract manufacturing market is fueled by the rising demand for pharmaceutical products. These products include medications or drugs designed to diagnose, prevent, treat, or cure diseases in humans or animals. Fill-finish pharmaceutical contract manufacturing is crucial for aseptically filling injectables, biologics, and other pharmaceutical items. This service guarantees precision, regulatory compliance, and efficient manufacturing processes while maintaining high product quality. For instance, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA) reported that total pharmaceutical production in Europe grew from $348 billion (€323.95 billion) in 2021 to $369.65 billion (€340 billion) in 2022. As a result, the increasing demand for pharmaceutical products is driving the growth of the fill-finish pharmaceutical contract manufacturing market.
The increasing drug development pipeline is anticipated to drive the growth of the fill-finish pharmaceutical contract manufacturing market in the coming years. The drug development pipeline encompasses the step-by-step process that a new pharmaceutical or therapeutic product undergoes, from initial discovery to market availability. Fill-finish pharmaceutical contract manufacturing is utilized in this pipeline to outsource the final stages of drug production, where the drug product is sterilized, filled into vials or syringes, sealed, and labeled. For example, in 2024, the European Federation of Pharmaceutical Industries and Associations, a Belgium-based trade association representing the pharmaceutical industry in Europe, reported that the global research and development pipeline increased from $363.3 billion in 2022 to $390 billion in 2023, highlighting a rise in investments and advancements in pharmaceutical research and development. Thus, the growth in the drug development pipeline is fueling the expansion of the fill-finish pharmaceutical contract manufacturing market.
Technological advancements emerge as a prominent trend in the fill-finish pharmaceutical contract manufacturing market. Companies within this sector are embracing innovative technologies to elevate product quality and adhere to stringent regulatory standards, ensuring their competitive position. For instance, in January 2023, Steriline s.r.l., an Italy-based provider specializing in aseptic solutions, introduced robotic technologies tailored for small-batch aseptic filling in January 2023. These robotic systems enhance safety and flexibility in producing both toxic and non-toxic pharmaceutical drugs, minimizing the risk of human error, improving product quality, and optimizing operational efficiency.
Leading companies in the fill-finish pharmaceutical contract manufacturing market prioritize the integration of cutting-edge capabilities such as lyophilization technologies. Lyophilization capabilities involve a facility's expertise in the lyophilization process, or freeze-drying, which is crucial for drying and preserving biological or pharmaceutical products by removing water content through sublimation. In February 2022, Recro Pharma, Inc., a US-based contract development and manufacturing organization (CDMO), introduced Lyophilization Aseptic Fill/Finish to its range of services. This suite includes a sterile, automated vial filling system capable of filling up to 2,000 pre-sterilized vials per hour across various volumes. The equipment can lyophilize approximately 9,000 10 mL vials in each freeze-drying cycle, typically spanning 3-5 days.
In March 2024, AstraZeneca, a biopharmaceutical company based in England, acquired Amolyt Pharma, enhancing its late-stage pipeline for rare diseases for an undisclosed amount. This acquisition aims to strengthen AstraZeneca's ability to develop innovative treatments for underserved patient populations, especially in the areas of rare endocrine and metabolic disorders. Amolyt Pharma, located in France, specializes in creating advanced therapeutics for individuals with rare endocrine and metabolic diseases.
Major companies operating in the fill-finish pharmaceutical contract manufacturing market include AbbVie Inc., Novartis AG, Thermo Fisher Scientific Inc., Fresenius Kabi, Abbott Laboratories, Eurofins Scientific SE, Lonza Group Ltd., Catalent Inc., Sun Pharmaceutical Industries Limited, West Pharmaceutical Services Inc., Patheon, Samsung Biologics Co.Ltd., WuXi Biologics, Piramal Pharma Solutions, Pfizer CentreOne, Recipharm AB, Emergent BioSolutions Inc., Boehringer Ingelheim BioXcellence, Corden Pharma GmbH, Aenova Group, Baxter BioPharma Solutions, FUJIFILM Diosynth Biotechnologies, AGC Biologics, Rentschler Biopharma SE, Recro Pharma Inc., Cobra Biologics Limited, Grand River Aseptic Manufacturing (GRAM), MabPlex International Ltd., Cerbios-Pharma SA, Symbiosis Pharmaceutical Services Limited
North America was the largest region in the fill-finish pharmaceutical contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fill-finish pharmaceutical contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the fill-finish pharmaceutical contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The fill-finish pharmaceutical contract manufacturing market includes revenues earned by entities by providing septic filling, packaging, labeling, and serialization services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Fill-Finish Pharmaceutical Contract Manufacturing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on fill-finish pharmaceutical contract manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for fill-finish pharmaceutical contract manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fill-finish pharmaceutical contract manufacturing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.